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Objective --To evaluate the results and complications of choledochoduode-
nostomy and choledochojejunostomy for benign and malignant disease and to review
them in the light of the survival of the underlying disorders.
Design Retrospective analysis of medical records completed by a thorough
inquiry for all patients who were lost to follow-up.
Setting Referrals for primary and secondary surgery for obstructive biliary disease
to a university hospital from 1974-1987.
Patients After exclusion of patients who underwent a pancreaticoduodenectomy
for cancer (Whipple procedure) 113 patients were included in the study (choledo-
choduodenostomy CD, N 64 and choledochojejunostomy CJ, N 49). A
complete follow-up was achieved in 105 of 113 patients (93%).
Interventions--An inquiry was made at the civil registration office if the patients
were alive or not. The general practitioners of the patients who had died were
contacted about the cause of death and the possible biliary symptoms preceding
death and the patients who were still alive received a questionaire which scrutinized
all possible complications and side effects of the operation.
Endpoints Cholangitis, recurrence of the underlying disease or death of the patient.
Measurements and main results--Operative mortality was4.7% following CD and
12.2% following CJ. Procedure-related complications were found in 10.9% and
28.6% respectively. Recurrent cholangitis was not seen after CD and in three patients
with a CJ (6.1%). Survival following biliodigestive anastomosis for benign obstruc-
tion was comparable for age and sex matched survival.
Conclusions Although CD for choledocholithiasis has largely been replaced by
endoscopic papillotomy and although the choice between the two procedures in
malignant disease is most frequently dictated by the operative findings, we conclude
that the choledochoduodenostomy is a relative simple operation with a low risk of
cholangitis.
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INTRODUCTION
Over the last ten years endoscopic papillotomy reduced the number of patients who
underwent surgery for bile duct stones and the procedure ofcholedochoduodenostomy
(CD) disappeared from the surgical practice in most centers. Consequently
choledochojejunostomy (CJ), which is used in cancer surgery, is preferred more and
more, even in benign disease. If a biliodigestive anastomosis is indicated the choice
between CD and CJ is usually determined by intraoperative considerations, about the
extension oftumour growth and the condition or the prognosis of the patient. There
are, however, situations when both techniques are optional. For instance, in case
of an impacted stone in the distal part of the common bile duct when preoper-
ative endoscopic papillotomy was not performed or unsticcessful.
The question arises: which type of biliodigestive anastomosis is preferable when a
choice is possible. Recurrent cholangitis, the most troublesome procedure related
complication, has been reported to occur in 0.4-10% of the patients after CD and
in 4.3-4.4% following CJ 1-5. As only one report2 comparing CD and CJ
could be found, we retrospectively analyzed the results of the biliodigestive
anastomoses performed in our hospital.
PATIENTS AND METHODS
The medical records of all patients who underwent CD or CJ form January 1974
through January 1987 were reveiwed. Because of the specific nature of the pro-
cedure, the CJ after pancreaticoduodenectomy for cancer (Whipple procedure)
was excluded from analysis. In this way 113 patients were included in the study: 56
males and 57 females with a mean age of 64.7 and 68.3 years respectively. From the
operation report information about the type ofanastomosis, the usage of a splint,
the duration of the operation and the estimated quantity of blood loss was acquired.
In addition, with respect to the assessment of survival, the patients were retrospec-
tively classified as to the indication for operation into three groups: stone formation,
carcinoma and exploration (miscellaneous disease). These groups were estab-
lished since survival is dependent on the type of the underlying disease. Therefore,
in this report, mortality is considered from two viewpoints: the type of biliodi-
gestive anastomosis and the indication for operation.
Techniques:
CD:
CJ:
A longitudinal incision ofat least 1.5 cm length wasmade in the dilated portion
of the common bile duct. After the Kocher manoeuver was carried out the
duodenum was brought, without tension, adjacent to the choledochotomy and
a transverse incision was made in the duodenum. The anastomosis was maRde by
a running one-layer suture using absorbable material (catgut, Vicryl or
R PDS ). Splinting of the anastomosis was used infrequently.
After opening the common bile duct as described above, an isolated jejunum
loop in the Roux-en-Y fashion was created by dividing the jejunum approxi-
mately 15 cm distal to the Treitz ligament. The distal end was closed by continu-
ous suture or staples and diverted through the mesentery of the transverse colon
to the common bile duct. A side-to-side anastomosis between the bile duct and
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simple running absorbable suture in one layer through the entire bowel wall.
Again splints were seldom applied. An end-to-side jejunojejunostomy be-
tween the afferent small bowel and the Roux-en-Y loop completed the
procedure.
Details about early and late complications and mortality were derived from the
medical records. All patients who had not visited the outpatient clinic recently were
verified to be alive at the civil registration office. With this information, at last
follow-up, 72 patients had died and three could not be traced. The local physicians
of the patients who had died were questioned about the cause of mortality and about
symptoms of cholangitis preceding the death ofthe patient. Consequently, with regard
to the surviving patients, an inquiry was conducted regarding the presence ofabdomi-
nal pain, fever chills or episodes ofjaundice. Questionnaires were sent to the remaining
38 patients and 33 were filled out correctly and returned (86.8% response rate). If
answers suggested signs or symptoms of cholangitis in the past or present, patients
were called to our clinic for verification of these symptoms and further evaluation.
With this method we achieved a complete follow-up in 105 of 113 patients (93%) with
a mean (SEM) of 34.4 (3.3) months (range: 9 days to 12 years) (62.5 (7.5) months
for the patients who were alive at last follow-up).
Data were subjected to computerized statistical analysis. Discrete variables were
analyzed by the chi-square test (Yate’s continuity correction used when necessary).
When two by two comparisons were made, the Fisher exact test was applied.
Continuous variables were subjected to analysis of variance (Non- parametric tests
used when necessa). Survival was assessed by life-table analysis as described by
Kaplan and Meier and compared with that expected in the Dutch population,
corresponding in age, sex and year of diagnosis. Life-tables were compared using the
log-rank test. All comparisons were two-tailed and p< 0.05 was considered significant.
RESULTS
Choledochoduodenostomy was performed in 64 cases (30 males and 34 females, mean
age -71.1 years) and choledochojejunostomy in 49 (26 males and 23 females, mean age
60.5 years). The duration of a CD-procedure was 120 7.2 minutes and of a CJ-pro-
cedure 165 7.5 minutes (median SEM). The estimated blood loss was 400 62.9 ml in
the CD-group and 700 141.1 ml in the CJ-group. A splint was used in 11 patients (6/64
CD and 5/49 CJ). The operation was performed as an emergency operation in 10 out
of 113 patients: seven with cholecystitis, cholangitis or gallstone-pancreatitis, one
with acalculous cholecystitis, one with a complication of percutaneous transhepatic
cholangiography and one with cholangitis after endoscopic papillotomy.
Stone formation was the underlying disease in 47 patients (41 CD and 6 CJ),
carcinoma in 50 (12 CD and 38 CJ) and miscellaneous disease in 16 (11 CD and 5 CJ).
Most cases (ight) of the latter group were benign obstructions of the papilla, and in
two cases the indication for operation was a iatrogenic choledochal duct lesion.
In 27 patients a cholecystectomy had been performed previously; in 81 patients the
gallbladder was removed as an adjuvant to the biliodigestive anastomosis and in one
patient an aplasia of the gallbladder was found, leaving only four patients who had
a biliodigestive anastomosis with the gallbladder in situ; a meaningful evaluation
regarding this condition could thus not be made.154 J.D. BLANKENSTEIJN AND O. T. TERPSTRA
Early mortality and complications
There were 9 deaths within thirty days of operation (9/113 8.0%): Three patients
died after a CD (3/64 4.7%) and six after a CJ (6/49 12.2%). In the group of
stone formation there was one death. This patient was operated upon because of
a cholangitis that had followed a failed endoscopic papillotomy and he died after a
period of septic shock, three weeks postoperatively. In the carcinoma-group six
patients died: five directly related to the cancer and one from cardiac failure. In the
miscellaneous-group two died: one from haemorrhagic shock and one from subphrenic
abscess.
Following CD seven of 64 patients (10.9%) had eight complications which
were related to theCD procedure: three bile leaks ofwhich two sealed spontaneously,
two haematoperitonea, two wound infections and one biliary obstruction. These
complications led to two reexplorations and one related death (a patient with biliary
obstruction and bile leakage). In 16 of the 64 patients (25%) with CD, 20 complica-
tions developed which were not related to theCD procedure: one bleeding gastric ulcer
(this patient survived after a successful reoperation), two cardiac, three pulmonary,
one thromboembolic and 13 other (minor)complications.
Following CJ 14 of49 patients (28.6%) had 16 complications which were related
to the CJ procedure. Five patients with postoperative bleeding were successfully
reoperated. Two of these patients, however, died after 14 and 28 days respectively:
one from preexisting liver cirrhosis and one from a further bleed caused by progres-
sion of the cancer. There were five bile leaks, of which four closed spontaneously,
and of which one was reoperated because ofan additional haematoperitoneum, four
wound infections and two biliary obstructions. In 10 of the 49 patients (20.4%) with
CJ, 11 complications developed which were not related to the CJ procedure: one
bleed caused by progression of cancer, one cardiac, five pulmonary and four other
(minor) complications. These data are summarized in Table 1.
Long term results
One hundred and four patients (46 stone formation, 44 carcinoma and 14 explor-
ation) survived the 30-days postoperative period. At last follow-up 62 ofthese patients
(61.4%) had died: 17 of 44 patients (38.6%) with stone formation, 39 of 43 (90.7%)
with carcinoma and six of 14 (42.9%) explorations. The survival curves ofthe groups
of stone formation and carcinoma are given in Figures and 2. Each curve is
accompanied by its corresponding expected survival curve of the Dutch population
matched for age, sex and year ofdiagnosis. Survival followingCD or CJ for biliary
stones is not different from the expected matched survival, but in case ofmalignant
disease this difference is remarkable.
Recurrent cholangitis
Recurrent cholangitis was found in none of 64 patients with CD and in three of 49
patients (6.1%) with CJ. The indication for the CJ in two of these three patients was
stone formation and a choledochal cyst in one patient. Because the mortality in the
CJ- group is considerably higher than in the CD-group, the average duration of the
postoperative period over which a patient is exposed to the risk of developing
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in both groups is inaccurate. Therefore the cumulative rates of recurrent cholangitis
are compared according to the life-table method and the logrank test. This revealed
the difference in cholangitis rate between the two groups of CD and CJ to be
statistically significant (P 0.0136).
There were no patients with pancreatitis after CD or CJ.
Table Summary of results and complications of choledochoduodenostomy (CD) and
choledochojejunostomy (CJ).
Type of anastomosis Total
CD (N= 64) CJ (N= 49) (N= 113)
Early mortality*"
N, % 3, 4.7 6, 12.2 9, 8.0
Procedure-related complications:
N (N-complic), % 7 (8), 10.9 14 (16), 28.6 21 (24), 18.6
Bile leak 3 5 8
Haematoperitoneum 2 5 7
Wound infection 2 4 6
Biliary obstruction 2 3
Other complications"
N (N-complic), % 16 (20), 25.0 10 (11), 20.4 26 (31), 23.0
Pulmonary 3 5 8
Cardiac 2 3
Gastro-intestinal bleeding 2
Thrombo-embolic
Other (minor) 13 4 17
DISCUSSION
Studies concerning the choice between the CD and CJ are scarce and, up until the
time of writing, all retrospective 2,7-9. Both procedures, however, appear to be
effective for many comparable indications.
Obviously the two groups ofCD and CJ in our study are not comparable. The
difference in the number of malignancies as the indication for operation in the
groups of CD and CJ is statistically significant: 12/64 CD (17.2%) and 38/49 CJ
(37.5%) (P<0.001) as well as the difference in age between these two groups
(P< 0.001). Therefore data concerning the duration of the operations, the amount of
blood loss, complications and early postoperative mortality are merely given for
descriptive reasons. However, there can be no doubt about the fact that a CD-proce-
dure is less extensive and less time-consuming. 10 The value of splinting the anastomosis is still controversial. In case of
thin-walled, not greatly dilated bile ducts it might prevent stenosis. Because in only
10% of our patients a splint was used, we could not analyze the possible benefits of
this adjunct.
The fact that six CJ’s were performed for stone formation and two CJ’s for benign
papillary obstructions confirms our concept that in some cases (less than 10%) a choice
between the two types of anastomosis is possible.
The rates ofcomplications which were related to the procedure are high: 10.9% for156 J.D. BLANKENSTEIJN AND O. T. TERPSTRA
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Figure 1 Cumulative survival by life table analysis of 47 patients following a biliodigestive anastomosis for
bile duct stones (bold curve) and the expected survival of the Dutch population matched for age, sex and
year of diagnosis (thin curve). Vertical ranges are 95% confidence limits. Numbers are the patients at risk.
the CD-grout and 28.6% for the CJ-group. This is consistent with earlier re-
ports1’4’9;’1-13. However, the varying indications for surgery and types of anasto-
moses in these reports as well as in our study, make the complication rates
incomparable.
In an earlier report a correlation was suggested between the creation of a CJ and
the development of a peptic ulcer, which may be related to the increased production
of the Gastro-Intestinal Polypeptide Hormone 14. This relation, however, is still con-
troversial3’15 and we could not confirm this finding as we only found one (bleeding)
peptic ulcer following CD. We were surprised by finding no patients with recurrent
cholangitis following CD despite our meticulous search.
Earlier studies reported a cholangitis rate of 2.6%-10% following a CD2-4but
in a collected series of 1255 patients, the incidence of cholangitis was only 0.40/05.
The two most important objections to CD are the ’ump syndrome" and
recurrent cholangitis. It is postulated that stones, sludge or food residue in the blind
common bile duct pouch are held responsible for the development of chp.la..ngitis,
jaundice or pancreatitis. However only few patient2s4re actually described’’’ and
many authors could not identify similar problemsRESULTS OF BILIODIGESTIVE ANASTOMOSIS 157
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Figure 2 Cumulative survival by life table analysis of 50 patients following a biliodigestive anastomosis for
cancer (bold curve) and the expected survival of the Dutch population matched for age, sex and year of
diagnosis (thin curve). Vertical ranges are 95% confidence limits. Numbers are the patients at risk.
Reflux of duodenal contents into the biliary system has been the presumed cause
of recurrent cholangitis but experimental studies showed that cholangitis only
developed in cases of a narrow or strictured anastomosis5. This finding is also of
importance with regard to the etiology of the sump syndrome.
The poor survival of the CJ-group as compared to its expected matched survival
and to the survival of the CD-group is explained by the fact that the former group
consists largely of patients who were not suitable for curative resection of a
malignant tumour of the pancreas, and ifi whom the CJ-procedure was performed
for palliation.
In view of this poor survival (which is consistent with previous reports9’11’18) we
believe that more attention should be given to palliative treatment of (impending)
biliary obstruction by carcinoma of the head of the pancreas. Results of radiotherapy
and chemotherapy are modest at best9. In case a decision about the type of anasto-
mosis is to be made, it is essential to consider the disappointing cumulative survival of
30% at one year. Effective bile drainage using endoscopic techniques of cho-
19 20" ledochoduodenostomy and endoprothesis placement, with lesser procedure
related complications as compared to biliodigestive anastomoses, have been de-
scribed. Not surprisingly many patients with obsruction of the distal portion of158 J.D. BLANKENSTEIJN AND O. T. TERPSTRA
the common bile duct are treated by endoscopic techniques nowadays or other
non-invasive procedures like lithotripsy or dissolution of stones.
From our study we conclude that CD is far from obsolete in the treatment of
common bile duct obstruction and still deserves it place in hepatobiliary surgery. It
is a relatively simple operation and even though reflux of duodenal contents into
the bile duct system may be considerable, it has low risk of cholangitis.
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